The Bristol biotech secured the backing to expand manufacturing capabilities and grow its footprint across European markets.
"Decarbonising construction cannot come at the expense of cost or performance. The challenge has been scaling biomaterials industrially and integrating them into real construction supply chains."
The Cornwall games studio will use the new capital to expand FireHawk FPV onto additional platforms and develop multiplayer capabilities.
"We’re incredibly proud of what our small team has achieved over the past two years. FireHawk FPV has demonstrated clear commercial potential and opened doors to major new markets. This follow‑on support from FSE enables us to accelerate development, expand our team with essential expertise, and pursue both gaming and B2B opportunities with confidence. We’re excited for the next phase of growth."
The pre-series A round was backed by The FSE Group through the South West Investment Fund.
"Difficulty taking tablets is a common problem in paediatrics but extends to adults experiencing swallow impairment, including those suffering from serious conditions such as stroke, dementia and some forms of cancer. Our liquid products are effective and stable at room temperature with a long shelf life, improving medication adherence, dosage accuracy and convenience for the NHS, patients, and caregivers. We are thrilled to receive this investment, which will help us make a significant impact on the global pharmaceutical landscape."